These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35307577)

  • 21. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
    Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
    Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison.
    Al-Salam S; Sharma C; Abu Sa'a MT; Afandi B; Aldahmani KM; Al Dhaheri A; Yahya H; Al Naqbi D; Al Zuraiqi E; Mohamed BK; Almansoori SA; Al Zaabi M; Al Derei A; Al Shamsi A; Kaabi JA
    PLoS One; 2021; 16(4):e0247807. PubMed ID: 33826647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-Up Strategies for Thyroid Nodules with Benign Cytology on Ultrasound-Guided Fine Needle Aspiration: Malignancy Rates of Management Guidelines Using Ultrasound Before and After the Era of the Bethesda System.
    Yoon JH; Lee HS; Kim EK; Moon HJ; Park VY; Kwak JY
    Thyroid; 2019 Sep; 29(9):1227-1236. PubMed ID: 31359839
    [No Abstract]   [Full Text] [Related]  

  • 24. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
    Kiernan CM; Solórzano CC
    J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Copy number alteration" as the sole molecular finding of a Thyroseq test is more commonly seen in Hurthle cell neoplasms.
    Kim TH; Rodriguez EF; Lim D; Moatamed NA
    Diagn Cytopathol; 2023 Nov; 51(11):705-711. PubMed ID: 37533334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytological results of ultrasound-guided fine-needle aspiration cytology for thyroid nodules: emphasis on correlation with sonographic findings.
    Lee MJ; Hong SW; Chung WY; Kwak JY; Kim MJ; Kim EK
    Yonsei Med J; 2011 Sep; 52(5):838-44. PubMed ID: 21786450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 5-tiered categorization system for reporting cytology is sufficient for management of patients with thyroid nodules compared to the 6-tiered Bethesda system.
    Koh J; Moon HJ; Kim EK; Kwak JY; Yoon JH
    Endocrine; 2016 Aug; 53(2):489-96. PubMed ID: 26758996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytology-Ultrasonography Risk-Stratification Scoring System Based on Fine-Needle Aspiration Cytology and the Korean-Thyroid Imaging Reporting and Data System.
    Hong MJ; Na DG; Baek JH; Sung JY; Kim JH
    Thyroid; 2017 Jul; 27(7):953-959. PubMed ID: 28463597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology.
    Campennì A; Giovanella L; Siracusa M; Alibrandi A; Pignata SA; Giovinazzo S; Trimarchi F; Ruggeri RM; Baldari S
    Thyroid; 2016 Aug; 26(8):1101-9. PubMed ID: 27266385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool.
    Garber JR; Papini E; Frasoldati A; Lupo MA; Harrell RM; Parangi S; Patkar V; Baloch ZW; Pessah-Pollack R; Hegedus L; Crescenzi A; Lubitz CC; Paschke R; Randolph GW; Guglielmi R; Lombardi CP; Gharib H
    Endocr Pract; 2021 Jul; 27(7):649-660. PubMed ID: 34090820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
    Kim J; Shin JH; Oh YL; Hahn SY; Park KW
    Endocr J; 2022 Jan; 69(1):67-74. PubMed ID: 34408101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
    Rosario PW
    Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American Association of Clinical Endocrinology And Associazione Medici Endocrinologi Thyroid Nodule Algorithmic Tool.
    Garber JR; Papini E; Frasoldati A; Lupo MA; Harrell RM; Parangi S; Patkar V; Baloch ZW; Pessah-Pollack R; Hegedus L; Crescenzi A; Lubitz CC; Paschke R; Randolph GW; Guglielmi R; Lombardi CP; Gharib H
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2104-2115. PubMed ID: 35026973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk Stratification in Patients With Follicular Neoplasm on Cytology: Use of Quantitative Characteristics and Sonographic Patterns.
    Wu MH; Chen KY; Hsieh MS; Chen A; Chen CN
    Front Endocrinol (Lausanne); 2021; 12():614630. PubMed ID: 33995270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy.
    Chung SR; Baek JH; Park HS; Choi YJ; Sung TY; Song DE; Kim TY; Lee JH
    Thyroid; 2017 May; 27(5):707-713. PubMed ID: 28326900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
    Desai D; Lepe M; Baloch ZW; Mandel SJ
    Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules.
    Hu TX; Nguyen DT; Patel M; Beckett K; Douek M; Masamed R; Rhyu J; Kim J; Tseng CH; Yeh MW; Livhits MJ
    Thyroid; 2022 Aug; 32(8):905-916. PubMed ID: 35611970
    [No Abstract]   [Full Text] [Related]  

  • 38. Predictive factors of malignancy in patients with cytologically suspicious for Hurthle cell neoplasm of thyroid nodules.
    Lee KH; Shin JH; Ko ES; Hahn SY; Kim JS; Kim JH; Oh YL
    Int J Surg; 2013; 11(9):898-902. PubMed ID: 23916366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparametric Ultrasound Evaluation of the Thyroid: Elastography as a Key Tool in the Risk Prediction of Undetermined Nodules (Bethesda III and IV)-Histopathological Correlation.
    Moraes PHM; Takahashi MS; Vanderlei FAB; Schelini MV; Chacon DA; Tavares MR; Chammas MC
    Ultrasound Med Biol; 2021 May; 47(5):1219-1226. PubMed ID: 33583638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
    Yoo MR; Gweon HM; Park AY; Cho KE; Kim JA; Youk JH; Son EJ
    PLoS One; 2015; 10(6):e0130138. PubMed ID: 26115096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.